Corteva, Inc. (NYSE:CTVA) Shares Bought by Handelsbanken Fonder AB

Handelsbanken Fonder AB raised its holdings in Corteva, Inc. (NYSE:CTVAFree Report) by 2.0% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 348,643 shares of the company’s stock after purchasing an additional 6,680 shares during the quarter. Handelsbanken Fonder AB’s holdings in Corteva were worth $16,707,000 as of its most recent filing with the SEC.

Other institutional investors also recently bought and sold shares of the company. Arcataur Capital Management LLC boosted its holdings in shares of Corteva by 2.4% in the third quarter. Arcataur Capital Management LLC now owns 8,598 shares of the company’s stock valued at $440,000 after acquiring an additional 200 shares in the last quarter. Union Savings Bank boosted its holdings in Corteva by 58.5% during the third quarter. Union Savings Bank now owns 577 shares of the company’s stock worth $30,000 after buying an additional 213 shares in the last quarter. Essex Financial Services Inc. boosted its holdings in Corteva by 3.2% during the third quarter. Essex Financial Services Inc. now owns 6,883 shares of the company’s stock worth $352,000 after buying an additional 215 shares in the last quarter. NewSquare Capital LLC boosted its holdings in Corteva by 70.6% during the third quarter. NewSquare Capital LLC now owns 546 shares of the company’s stock worth $28,000 after buying an additional 226 shares in the last quarter. Finally, Tradewinds LLC. boosted its holdings in Corteva by 5.1% during the third quarter. Tradewinds LLC. now owns 4,788 shares of the company’s stock worth $245,000 after buying an additional 231 shares in the last quarter. 81.54% of the stock is currently owned by institutional investors and hedge funds.

Corteva Price Performance

Shares of CTVA stock opened at $55.20 on Tuesday. The company has a market capitalization of $38.58 billion, a PE ratio of 54.12, a price-to-earnings-growth ratio of 1.44 and a beta of 0.77. The firm has a fifty day simple moving average of $55.23 and a 200-day simple moving average of $50.33. The company has a current ratio of 1.56, a quick ratio of 0.90 and a debt-to-equity ratio of 0.09. Corteva, Inc. has a twelve month low of $43.22 and a twelve month high of $61.87.

Corteva (NYSE:CTVAGet Free Report) last announced its earnings results on Thursday, February 1st. The company reported $0.15 earnings per share for the quarter, beating the consensus estimate of $0.06 by $0.09. The business had revenue of $3.71 billion during the quarter, compared to the consensus estimate of $3.54 billion. Corteva had a net margin of 4.27% and a return on equity of 7.43%. During the same period in the prior year, the firm earned $0.16 earnings per share. Equities research analysts anticipate that Corteva, Inc. will post 2.84 earnings per share for the current fiscal year.

Corteva Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Friday, March 15th. Shareholders of record on Friday, March 1st were paid a dividend of $0.16 per share. The ex-dividend date was Thursday, February 29th. This represents a $0.64 dividend on an annualized basis and a yield of 1.16%. Corteva’s dividend payout ratio (DPR) is 62.75%.

Analyst Upgrades and Downgrades

Several analysts have issued reports on the stock. Mizuho reduced their price target on shares of Corteva from $59.00 to $56.00 and set a “buy” rating on the stock in a report on Thursday, February 1st. UBS Group cut their price objective on shares of Corteva from $65.00 to $64.00 and set a “buy” rating for the company in a research report on Thursday, January 11th. Barclays boosted their price objective on shares of Corteva from $55.00 to $58.00 and gave the company an “equal weight” rating in a research report on Wednesday, April 10th. Loop Capital raised shares of Corteva from a “hold” rating to a “buy” rating and boosted their price objective for the company from $57.00 to $65.00 in a research report on Monday, February 12th. Finally, BNP Paribas raised shares of Corteva from an “underperform” rating to a “neutral” rating and set a $53.00 price target for the company in a research report on Friday, February 2nd. Six equities research analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $63.29.

Get Our Latest Report on CTVA

Corteva Company Profile

(Free Report)

Corteva, Inc operates in the agriculture business. It operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics.

See Also

Want to see what other hedge funds are holding CTVA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Corteva, Inc. (NYSE:CTVAFree Report).

Institutional Ownership by Quarter for Corteva (NYSE:CTVA)

Receive News & Ratings for Corteva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Corteva and related companies with MarketBeat.com's FREE daily email newsletter.